ORTHOCON Announces New President, $25 Million In Financing

Big news at ORTHOCON, DeviceSpace reports. The New Jersey-based company, which develops devices that deliver therapeutics to bone, recently announced the appointment of a new CEO and the closing of $25 million in Series B funding.

Read more »